STOCK TITAN

Elanco Animal Health (NYSE: ELAN) awards CFO new deferred stock units

(Neutral)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

VanHimbergen Robert M reported acquisition or exercise transactions in this Form 4 filing.

Elanco Animal Health’s EVP and CFO, Robert M. VanHimbergen, received a grant of 7.9380 deferred stock units on 2026-07-10 at a reference value of $24.8200 per unit. Each unit represents the right to receive one share of common stock or the cash equivalent under the Executive Deferral and Stock Match Plan and will settle after employment ends or in a specified future year. Following this award, he holds 116.7886 deferred stock units directly.

Positive

  • None.

Negative

  • None.
Insider VanHimbergen Robert M
Role EVP and CFO
Type Security Shares Price Value
Grant/Award Deferred Stock Units F1, F2 7.938 $24.82 $197.02
Holdings After Transaction: Deferred Stock Units — 116.7886 shares (Direct)
Footnotes (2)
  1. F1. Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent.
  2. F2. Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan.
Deferred stock units granted 7.9380 units Grant to EVP and CFO Robert M. VanHimbergen on 2026-07-10
Reference price per deferred unit $24.8200 Value used for the 7.9380 deferred stock units granted
Deferred stock units after grant 116.7886 units Total deferred stock units held directly after the award
Transaction date 2026-07-10 Date of the deferred stock unit award
Deferred Stock Units financial
"Security titled 'Deferred Stock Units' granted to the EVP and CFO"
Deferred stock units are promises from a company to give an employee shares of stock at a future date, often after certain conditions are met or after leaving the company. They function like a form of delayed compensation, allowing employees to earn shares over time. For investors, they represent potential future ownership in the company, but do not provide immediate voting rights or dividends until the shares are actually received.
cash equivalent financial
"Right to receive one share of common stock or the cash equivalent"
Executive Deferral and Stock Match Plan financial
"Settles in accordance with the Executive Deferral and Stock Match Plan"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What insider transaction did Elanco Animal Health (ELAN) report for its CFO?

Elanco reported that CFO Robert M. VanHimbergen received a grant of 7.9380 deferred stock units. These units reference $24.8200 per unit and increase his direct deferred stock unit holdings to 116.7886 units under the company’s Executive Deferral and Stock Match Plan.

Is the Elanco (ELAN) CFO’s Form 4 transaction a market purchase or sale?

The Form 4 shows a grant/award acquisition of deferred stock units, not an open-market purchase or sale. The transaction uses code A, indicating compensation-related units awarded under a company plan rather than discretionary buying or selling in the market.

How many deferred stock units does the Elanco (ELAN) CFO hold after this award?

After the 7.9380-unit grant, the CFO directly holds 116.7886 deferred stock units. These units represent rights tied to Elanco common stock or cash equivalents and will settle following termination of employment or in a specified future year, as specified by the company plan.

What does each deferred stock unit represent in the Elanco (ELAN) CFO’s award?

Each deferred stock unit represents the right to receive one share of Elanco common stock or the cash equivalent. Settlement occurs in cash or shares after employment ends or during a specified future year, following the terms of the Executive Deferral and Stock Match Plan.

When will the Elanco (ELAN) CFO’s deferred stock units settle?

The deferred stock units will settle in cash or shares following the CFO’s termination of employment or during a specified future year. The exact timing is governed by Elanco’s Executive Deferral and Stock Match Plan, which controls distribution elections and settlement conditions.

What was the reference value used for the Elanco (ELAN) CFO’s deferred stock unit grant?

The 7.9380 deferred stock units granted to the CFO used a reference value of $24.8200 per unit. This price is used to measure the size of the award but the units themselves are payable later in shares of common stock or their cash equivalent.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
VanHimbergen Robert M

(Last)(First)(Middle)
C/O ELANCO ANIMAL HEALTH INCORPORATED
450 ELANCO CIRCLE

(Street)
INDIANAPOLIS INDIANA 46221

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Elanco Animal Health Inc [ ELAN ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
EVP and CFO
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
07/10/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Deferred Stock Units(1)07/10/2026A7.938 (2) (2)Common Stock7.938$24.82116.7886D
Explanation of Responses:
1. Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent.
2. Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan.
/s/ Amy C. Seidel, as Attorney-in-Fact for Robert M. VanHimbergen07/14/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)